[go: up one dir, main page]

DK0521353T3 - Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf - Google Patents

Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf

Info

Publication number
DK0521353T3
DK0521353T3 DK92110347.9T DK92110347T DK0521353T3 DK 0521353 T3 DK0521353 T3 DK 0521353T3 DK 92110347 T DK92110347 T DK 92110347T DK 0521353 T3 DK0521353 T3 DK 0521353T3
Authority
DK
Denmark
Prior art keywords
methylpiperidino
preparation
phosphate
ethyl
active ingredient
Prior art date
Application number
DK92110347.9T
Other languages
Danish (da)
English (en)
Inventor
Juergen Prof Engel
Wolfgang Dr Schumacher
Gerhard Dr Noessner
Bernhard Dr Kutscher
Jurij Dr Stekar
Peter Dr Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Application granted granted Critical
Publication of DK0521353T3 publication Critical patent/DK0521353T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/59—Hydrogenated pyridine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
DK92110347.9T 1991-07-04 1992-06-19 Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf DK0521353T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4122140 1991-07-04
DE4129364 1991-09-04

Publications (1)

Publication Number Publication Date
DK0521353T3 true DK0521353T3 (da) 1996-05-13

Family

ID=25905206

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92110347.9T DK0521353T3 (da) 1991-07-04 1992-06-19 Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf

Country Status (19)

Country Link
US (1) US5219866A (zh)
EP (1) EP0521353B1 (zh)
JP (1) JP3176720B2 (zh)
KR (1) KR100255436B1 (zh)
CN (1) CN1030658C (zh)
AT (1) ATE136783T1 (zh)
AU (1) AU651224B2 (zh)
CA (1) CA2073146C (zh)
DE (2) DE4219972A1 (zh)
DK (1) DK0521353T3 (zh)
EG (1) EG20082A (zh)
ES (1) ES2086026T3 (zh)
FI (1) FI108035B (zh)
GR (1) GR3019776T3 (zh)
HU (2) HUT61561A (zh)
IE (1) IE73200B1 (zh)
IL (1) IL102380A (zh)
NO (1) NO303939B1 (zh)
PL (3) PL173905B1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ538428A (en) * 2002-07-30 2006-09-29 Zentaris Gmbh Use of alkylphosphocholines in combination with antitumor medicaments
US8383605B2 (en) * 2002-07-30 2013-02-26 Aeterna Zentaris Gmbh Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals
AU2006328479B2 (en) * 2005-12-19 2012-03-08 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
CN101340918B (zh) * 2005-12-19 2012-10-03 阿特纳赞塔里斯有限公司 具有降低细胞毒性的新烷基磷脂衍生物及其用途
JP5068630B2 (ja) * 2007-11-15 2012-11-07 オルガノ株式会社 アルコール含有溶液中のアルデヒド化合物の除去方法及び該方法により精製された醸造酒
CA2794513A1 (en) 2010-03-31 2011-10-06 Aeterna Zentaris Gmbh Perifosine and capecitabine as a combined treatment for cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU301951A1 (ru) * 1970-06-01 1973-04-05 В. А. Чернов, Т. С. Сафонова, Н. В. Сазонов, А. А. Кропачева, Лекарственное средство
JPS5984824A (ja) * 1982-11-08 1984-05-16 Takeda Chem Ind Ltd 抗腫瘍剤
EP0521297B1 (de) * 1991-07-04 1997-09-17 ASTA Medica Aktiengesellschaft Verfahren zur Herstellung von Alkylphosphocholinen und Reinherstellung derselben

Also Published As

Publication number Publication date
ATE136783T1 (de) 1996-05-15
FI923088A0 (fi) 1992-07-03
IL102380A (en) 1996-10-16
AU651224B2 (en) 1994-07-14
CN1068119A (zh) 1993-01-20
FI923088L (fi) 1993-01-05
PL173869B1 (pl) 1998-05-29
HUT61561A (en) 1993-01-28
PL173794B1 (pl) 1998-05-29
NO303939B1 (no) 1998-09-28
PL173905B1 (pl) 1998-05-29
JP3176720B2 (ja) 2001-06-18
CN1030658C (zh) 1996-01-10
EG20082A (en) 1997-05-31
EP0521353A1 (de) 1993-01-07
ES2086026T3 (es) 1996-06-16
IE73200B1 (en) 1997-05-07
AU1943592A (en) 1993-03-11
KR930001909A (ko) 1993-02-22
DE59205998D1 (de) 1996-05-23
EP0521353B1 (de) 1996-04-17
IL102380A0 (en) 1993-01-14
GR3019776T3 (en) 1996-07-31
NO922642L (no) 1993-01-05
DE4219972A1 (de) 1993-01-07
JPH05213980A (ja) 1993-08-24
NO922642D0 (no) 1992-07-03
HU211483A9 (en) 1995-11-28
CA2073146A1 (en) 1993-01-05
IE922183A1 (en) 1993-01-13
CA2073146C (en) 2002-05-28
HU9202232D0 (en) 1992-10-28
US5219866A (en) 1993-06-15
KR100255436B1 (ko) 2000-05-01
PL295128A1 (en) 1993-08-23
FI108035B (fi) 2001-11-15

Similar Documents

Publication Publication Date Title
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ATE2667T1 (de) Antidepressiv wirkende derivate des trans-4phenyl-1,2,3,4-tetrahydro-1-naphthalin-amins und pharmazeutische zusammensetzungen daraus.
ITRM920361A1 (it) Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo.
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
FI960032L (fi) Farmaseuttisia koostumuksia vaikeasti liukenevia aktiiviaineita varten
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
MX9205280A (es) Derivados de benzanilida, procedimiento para su preparacion y composicion farmaceutica que los contiene.
MX9202289A (es) Nuevos derivados de tiopiranopirrol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9202619A (es) Derivados de oxa tiolano cristalino, metodo para su preparacion y formulacion farmaceutica que los contiene.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
DE69808130D1 (de) Adamantan-derivate
NL930038I2 (nl) Farmaceutische preparaten, welke een invloed op demaagzuurafscheiding bezitten en ten minste een qu anidinothiazoolderivaat als werkzame stof bevattenalsmede de voor gebruik in dergelijke preparaten geschikte quanidinothiazoolderivaten.
DE60019334D1 (de) Antivirale arznei
DE69923336D1 (de) Oral anzuwendende buprenorphinhaltige arzneimittel
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
MX9205155A (es) Derivados heterociclicos n-substituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
FI945975L (fi) Haarautuneella aminoryhmällä substituoituja tiatsoleja, menetelmiä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DZ1559A1 (fr) Compositions pharmaceutiques.
DK0521353T3 (da) Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf
MX9204395A (es) Derivados de 3-desoxi-manosamina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DK0668290T3 (da) Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
ITMI912745A0 (it) Derivati 5h-benzodiazepinici, composizioni farmaceutiche che li contengono e procedimento per la loro preparazione.
DK0469440T3 (da) Faste orale applikationsformer, der som aktivt stof indeholder ifosamid
ES2087178T3 (es) Disulfato de ws7622a, procedimiento para su preparacion y su uso.